Bellicum Pharmaceuticals Inc (BLCM.OQ)
22 Nov 2017
Tue, Nov 7 2017
* Bellicum Pharmaceuticals Inc qtrly earnings per share loss $0.71
BRIEF-Bellicum Pharmaceuticals enters a cancer research grant contract with cancer prevention and research institute of Texas
* Bellicum Pharmaceuticals says on Aug. 9, entered a cancer research grant contract with cancer prevention and research institute of Texas
* Bellicum pharmaceuticals reports second quarter 2017 financial results and provides corporate update
* Bellicum Pharmaceuticals Inc files for mixed shelf offering of upto $150 million - sec filing Source text: (http://bit.ly/2tmwwmp) Further company coverage:
BRIEF-Bellicum Pharmaceuticals files prospectus relating to disposition of up to about 5 million shares
* Bellicum Pharmaceuticals files prospectus relating to disposition of up to about 5 million shares of co's common stock held by the selling stockholders
- Adaptimmune: Is Now The Time To Adopt This Stock For Your Stock Portfolio?
- How Is Bellicum's Momentum Heading Into ASH 2017?
- Bellicum Pharmaceuticals (BLCM) Presents At Jefferies 2017 London Healthcare Conference - Slideshow
- Will Biotech Continue To Boom?
- Bellicum Pharmaceuticals (BLCM) Presents At Ladenburg Thalmann 2017 Healthcare Conference - Slideshow
- CAR-T Therapy FDA Approved - Slingshot Insights' Idea Of The Month